Smith+Nephew (UK) and Organogenesis Inc. (US) are Leading Players in the Bioactive Dressings Market
The global bioactive dressings market is projected to reach USD 5.8 billion by 2029 from USD 3.5 billion in 2024, at a CAGR of 10.5% during the forecast period. The bioactive dressings market is primarily driven by the increasing prevalence of chronic wounds including diabetes and vascular disorders, technological advancements in bioactive dressings, and aging population. Additionally supportive healthcare initiatives and strategic collaborations between market players further drive the demand for bioactive dressings.
The bioactive dressings market is consolidated and is dominated by few players. The major players operating in this market are Smith+Nephew (UK), Organogenesis Inc. (US), Mimedx Group, Inc. (US), 3M (US) and Cardinal Health (US). These include product launches, contracts, partnerships, mergers and acquisitions, and new product development activities to further expand their presence in the pipette calibrators market.
To know about the assumptions considered for the study download the pdf brochure
SMITH+NEPHEW (UK)
In 2023, Smith+Nephew (UK) held the leading position in the bioactive dressings market. The company has maintained its market leadership through a strong distribution network in North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. Smith+Nephew has a strong distribution network across the globe. This helps in insulating its business from demand fluctuations in various geographies. The company has majorly adopted inorganic strategies to sustain its presence in this market. Smith+Nephew focuses on strategies such as agreements, expansion and acquisitions to garner a larger market share.
ORGANOGENESIS INC. (US)
In 2023, Organogenesis Inc. (US) was the second largest bioactive dressing market. The company offers a wide range of bioactive dressing products, including collagen dressings and human placenta grafts. The company’s products are designed to meet the unique needs of different types of wounds, including pressure ulcers, diabetic foot ulcers, and surgical wounds. The company’s leading position in this market can be attributed to its increased focus on R&D to develop unique and better products than its competitors. Investments in R&D to optimize portfolio and capital allocation strategy help drive future growth and ability to remain competitive in the bioactive sanitary napkin segment.
MIMEDX GROUP, INC. (US)
MiMedx Group, Inc. held the third position in the global bioactive dressings market in 2023. The company has a good product portfolio, and its FDA approved products have helped it gain a sizable share of the bioactive dressings market. Apart from this, MiMedx also invests a huge amount of its revenue in R&D to develop new products in the bioactive dressings market. In order to maintain its leading position in the bioactive dressings market, the company focuses on organic and inorganic growth strategies such as product launches and collaborations.
Related Reports:
Bioactive Dressings Market by Product (Collagen, Alginate, Chitosan, Skin Substitute), Property (Antimicrobial, Non-antimicrobial), Application (Chronic Wounds (Diabetic Foot, Pressure Ulcers), Acute Wounds (Surgical, Burns))- Global Forecast to 2029
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
